Item(by='koheripbal', descendants=None, kids=None, score=None, time=1602888310, title=None, item_type='comment', url=None, parent=24805591, text='The biggest limitation to this drug is that it <i>probably</i> works very well IF given in the first 12 hours of infection when viral replication is highest.<p>The problem is that since it&#x27;s intravenous, it&#x27;s hard to justify giving it to people BEFORE they seem sick.<p>Naturally patients and doctors are pressured to treat the sickest patients first, and so <i>they</i> get the Remdesivir, despite it likely not doing much so late in sickness.<p>Ideally, if we could identify people highest at risk, and early in their disease - THEY should be given the drug very rapidly.  ...but again, without that identification step, it&#x27;s very hard to justify giving someone an experimental treatment.')